Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neural Inertia in Humans With Xenon
NCT02768727Phase 2Completed
- Sponsor
- University of Pennsylvania
- Start
- Apr 2016
- Primary completion
- Dec 2019
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of xenon, sponsored by University of Pennsylvania. Primary endpoint: Xenon Concentrations at Which Consciousness is Lost and Regained at 4 hours. Started Apr 2016; status: completed.
02
Drugs
xenon
Beyond the preview
Go deeper on NCT02768727.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02768727.